Endothelial Dysfunction and Nailfold Videocapillaroscopy Pattern as Predictors of Digital Ulcers in Systemic Sclerosis: a Cohort Study and Review of the Literature

Clinical Reviews in Allergy and Immunology

Volumn 49, Issue 2, 2015, Pages 240-252

  Silva, Ivone ^a,b   Teixeira, Andreia ^c   Oliveira, José ^a   Almeida, Isabel ^b   Almeida, Rui ^a   Águas, Artur ^c   Vasconcelos, Carlos ^b,c  

^a Institute of Biomedical Sciences Abel Salazar   (Portugal)

^b Clinical Immunology Unit   (Portugal)

^c UNIVERSITY OF PORTO   (Portugal)

Author keywords

Capillaroscopy; Digital ulcer; Endothelin 1; Flow mediated dilatation; VEGF

Indexed keywords

ENDOGLIN; ENDOSTATIN; ENDOTHELIN 1; N(G),N(G) DIMETHYLARGININE; VASCULOTROPIN; BIOLOGICAL MARKER; CELL SURFACE RECEPTOR; ENG PROTEIN, HUMAN; LEUKOCYTE ANTIGEN; VASCULOTROPIN A;

ADULT; ALLEN TEST; ANALYTICAL PARAMETERS; AREA UNDER THE CURVE; ARTICLE; CALCINOSIS; CAPILLAROSCOPY; CLINICAL FEATURE; COHORT ANALYSIS; CONTRACTURE; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC TEST ACCURACY STUDY; DIGITAL PITTING SCAR; DISEASE ASSOCIATION; DISEASE DURATION; ENDOTHELIAL DYSFUNCTION; FEMALE; FINGER ULCER; FLOW MEDIATED DILATATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NAILFOLD VIDEOCAPILLAROSCOPY; OUTCOME ASSESSMENT; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RECURRENT DISEASE; RISK ASSESSMENT; SCLERODACTILY; SENSITIVITY AND SPECIFICITY; SYSTEMIC SCLEROSIS; TELANGIECTASIA; ADOLESCENT; AGED; ANGIOSCOPY; BLOOD; COMPLICATION; ENDOTHELIUM; FINGER; FOLLOW UP; METABOLISM; PATHOLOGY; PREDICTIVE VALUE; PROGNOSIS; RAYNAUD DISEASE; SCLERODERMA, SYSTEMIC; ULCER; VASCULARIZATION; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANTIGENS, CD; BIOMARKERS; COHORT STUDIES; ENDOTHELIN-1; ENDOTHELIUM; FEMALE; FINGERS; FOLLOW-UP STUDIES; HUMANS; MALE; MICROSCOPIC ANGIOSCOPY; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; RAYNAUD DISEASE; RECEPTORS, CELL SURFACE; SCLERODERMA, SYSTEMIC; ULCER; VASCULAR ENDOTHELIAL GROWTH FACTOR A; YOUNG ADULT;

EID: 84944071449     PISSN: 10800549     EISSN: 15590267     Source Type: Journal    
DOI: 10.1007/s12016-015-8500-0     Document Type: Article

References (69)

1. Muller-Ladner U, Distler O, Ibba-Manneschi L, Neumann E, Gay S (2009) Mechanisms of vascular damage in systemic sclerosis. Autoimmunity 42(7):587–595
2. Ghizzoni C, Sebastiani M, Manfredi A, Campomori F, Colaci M, Giuggioli D et al (2015) Prevalence and evolution of scleroderma pattern at nailfold videocapillaroscopy in systemic sclerosis patients: clinical and prognostic implications. Microvasc Res 99:92–95
3. Flavahan NA (2008) Regulation of vascular reactivity in scleroderma: new insights into Raynaud’s phenomenon. Rheum Dis Clin N Am 34(1):81–87, vii
4. Hummers LK, Hall A, Wigley FM, Simons M (2009) Abnormalities in the regulators of angiogenesis in patients with scleroderma. J Rheumatol 36(3):576–582
5. Galluccio F, Matucci-Cerinic M (2011) Two faces of the same coin: Raynaud phenomenon and digital ulcers in systemic sclerosis. Autoimmun Rev 10(5):241–243
6. Amanzi L, Braschi F, Fiori G, Galluccio F, Miniati I, Guiducci S et al (2010) Digital ulcers in scleroderma: staging, characteristics and sub-setting through observation of 1614 digital lesions. Rheumatology (Oxford, England) 49(7):1374–1382
7. Merkel PA, Herlyn K, Martin RW, Anderson JJ, Mayes MD, Bell P et al (2002) Measuring disease activity and functional status in patients with scleroderma and Raynaud’s phenomenon. Arthritis Rheum 46(9):2410–2420
8. Hachulla E, Clerson P, Launay D, Lambert M, Morell-Dubois S, Queyrel V et al (2007) Natural history of ischemic digital ulcers in systemic sclerosis: single-center retrospective longitudinal study. J Rheumatol 34(12):2423–2430
9. Hudson M, Fritzler MJ (2014) Diagnostic criteria of systemic sclerosis. J Autoimmun 48–49:38–41
10. Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA et al (2002) Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 39(2):257–265
11. Cutolo M, Pizzorni C, Secchi ME, Sulli A (2008) Capillaroscopy. Best Pract Res Clin Rheumatol 22(6):1093–1108
12. Avouac J, Walker UA, Hachulla E, Riemekasten G, Cuomo G, Carreira PE, et al. (2014) Joint and tendon involvement predict disease progression in systemic sclerosis: a EUSTAR prospective study. Ann Rheum Dis
13. Matucci-Cerinic M, Denton CP, Furst DE, Mayes MD, Hsu VM, Carpentier P et al (2011) Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial. Ann Rheum Dis 70(1):32–38
14. Korn JH, Mayes M, Matucci Cerinic M, Rainisio M, Pope J, Hachulla E et al (2004) Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonist. Arthritis Rheum 50(12):3985–3993
15. Manfredi A, Sebastiani M, Carraro V, Iudici M, Bocci M, Vukatana G, et al. (2014) Prediction risk chart for scleroderma digital ulcers: a composite predictive model based on capillaroscopic, demographic and clinico-serological parameters. Clin hemorheol Microcirc
16. Avouac J, Fransen J, Walker UA, Riccieri V, Smith V, Muller C et al (2011) Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group. Ann Rheum Dis 70(3):476–481
17. Silva I, Almeida J, Vasconcelos C (2015) A PRISMA-driven systematic review for predictive risk factors of digital ulcers in systemic sclerosis patients. Autoimmun Rev 14(2):140–152
18. Cutolo M, Smith V (2013) State of the art on nailfold capillaroscopy: a reliable diagnostic tool and putative biomarker in rheumatology? Rheumatology (Oxford, England) 52(11):1933–1940
19. Rossi D, Russo A, Manna E, Binello G, Baldovino S, Sciascia S et al (2013) The role of nail-videocapillaroscopy in early diagnosis of scleroderma. Autoimmun Rev 12(8):821–825
20. Caramaschi P, Canestrini S, Martinelli N, Volpe A, Pieropan S, Ferrari M et al (2007) Scleroderma patients nailfold videocapillaroscopic patterns are associated with disease subset and disease severity. Rheumatology (Oxford, England) 46(10):1566–1569
21. Smith V, Decuman S, Sulli A, Bonroy C, Piettte Y, Deschepper E et al (2012) Do worsening scleroderma capillaroscopic patterns predict future severe organ involvement? a pilot study. Ann Rheum Dis 71(10):1636–1639
22. Lambova S, Muller-Ladner U (2011) Capillaroscopic findings in systemic sclerosis -- are they associated with disease duration and presence of digital ulcers? Discov Med 12(66):413–418
23. Alivernini S, De Santis M, Tolusso B, Mannocci A, Bosello SL, Peluso G et al (2009) Skin ulcers in systemic sclerosis: determinants of presence and predictive factors of healing. J Am Acad Dermatol 60(3):426–435
24. Sulli A, Secchi ME, Pizzorni C, Cutolo M (2008) Scoring the nailfold microvascular changes during the capillaroscopic analysis in systemic sclerosis patients. Ann Rheum Dis 67(6):885–887
25. Smith V, De Keyser F, Pizzorni C, Van Praet JT, Decuman S, Sulli A et al (2011) Nailfold capillaroscopy for day-to-day clinical use: construction of a simple scoring modality as a clinical prognostic index for digital trophic lesions. Ann Rheum Dis 70(1):180–183
26. Sebastiani M, Manfredi A, Colaci M, D’Amico R, Malagoli V, Giuggioli D et al (2009) Capillaroscopic skin ulcer risk index: a new prognostic tool for digital skin ulcer development in systemic sclerosis patients. Arthritis Rheum 61(5):688–694
27. Kim HS, Park MK, Kim HY, Park SH (2010) Capillary dimension measured by computer-based digitalized image correlated with plasma endothelin-1 levels in patients with systemic sclerosis. Clin Rheumatol 29(3):247–254
28. Ennis H, Moore T, Murray A, Vail A, Herrick AL (2014) Further confirmation that digital ulcers are associated with the severity of abnormality on nailfold capillaroscopy in patients with systemic sclerosis. Rheumatology (Oxford, England) 53(2):376–377
29. Cutolo MHA, Distler O et al (2013) Nailfold videocapillaroscopy and other predictive factors associated with new digital ulcers in systemic sclerosis. Data from the CAP study. Ann Rheum Dis 72(S3):146
30. Sebastiani M, Manfredi A, Vukatana G, Moscatelli S, Riato L, Bocci M et al (2012) Predictive role of capillaroscopic skin ulcer risk index in systemic sclerosis: a multicentre validation study. Ann Rheum Dis 71(1):67–70
31. Sebastiani M, Manfredi A, Lo Monaco A, Praino E, Riccieri V, Grattagliano V et al (2013) Capillaroscopic Skin Ulcers Risk Index (CSURI) calculated with different videocapillaroscopy devices: how its predictive values change. Clin Exp Rheumatol 31(2 Suppl 76):115–117
32. Sebastiani M, Manfredi A, Cassone G, Giuggioli D, Ghizzoni C, Ferri C (2014) Measuring microangiopathy abnormalities in systemic sclerosis patients: the role of capillaroscopy-based scoring models. Am J Med Sci
33. Zhang L, Wan YN, Zhao JH, Wang YJ, Wang YX, Yan JW, et al. (2014) The Association Between Systemic Sclerosis, Arginine and Asymmetric Dimethylarginine. Inflammation
34. Kahaleh B, Mulligan-Kehoe MJ (2012) Mechanisms of Vascular Disease. J. Varga et al. (eds), Scleroderma: from pathogenesis to comprehensive managment:227–46
35. Kim NH, Rubin LJ (2002) Endothelin in health and disease: endothelin receptor antagonists in the management of pulmonary artery hypertension. J Cardiovasc Pharmacol Ther 7(1):9–19
36. Kahaleh MB, Sherer GK, LeRoy EC (1979) Endothelial injury in scleroderma. J Exp Med 149(6):1326–1335
37. Yamane K, Miyauchi T, Suzuki N, Yuhara T, Akama T, Suzuki H et al (1992) Significance of plasma endothelin-1 levels in patients with systemic sclerosis. J Rheumatol 19(10):1566–1571
38. Sulli A, Soldano S, Pizzorni C, Montagna P, Secchi ME, Villaggio B et al (2009) Raynaud’s phenomenon and plasma endothelin: correlations with capillaroscopic patterns in systemic sclerosis. J Rheumatol 36(6):1235–1239
39. Aghaei M, Gharibdost F, Zayeni H, Akhlaghi M, Sedighi S, Rostamian AR et al (2012) Endothelin-1 in systemic sclerosis. Indian Dermatol Online J 3(1):14–16
40. Cozzani E, Javor S, Laborai E, Drosera M, Parodi A (2013) Endothelin-1 levels in scleroderma patients: a pilot study. ISRN Dermatol 2013:125632
41. Dimitroulas T, Sandoo A, Kitas GD (2012) Asymmetric dimethylarginine as a surrogate marker of endothelial dysfunction and cardiovascular risk in patients with systemic rheumatic diseases. Int J Mol Sci 13(10):12315–12335
42. Dooley A, Gao B, Bradley N, Abraham DJ, Black CM, Jacobs M et al (2006) Abnormal nitric oxide metabolism in systemic sclerosis: increased levels of nitrated proteins and asymmetric dimethylarginine. Rheumatology (Oxford, England) 45(6):676–684
43. Cotton SA, Herrick AL, Jayson MI, Freemont AJ (1999) Endothelial expression of nitric oxide synthases and nitrotyrosine in systemic sclerosis skin. J Pathol 189(2):273–278
44. Pyke KE, Tschakovsky ME (2005) The relationship between shear stress and flow-mediated dilatation: implications for the assessment of endothelial function. J Physiol 568(Pt 2):357–369
45. Harris RA, Nishiyama SK, Wray DW, Richardson RS (2010) Ultrasound assessment of flow-mediated dilation. Hypertension 55(5):1075–1085
46. Au K, Singh MK, Bodukam V, Bae S, Maranian P, Ogawa R et al (2011) Atherosclerosis in systemic sclerosis: a systematic review and meta-analysis. Arthritis Rheum 63(7):2078–2090
47. Takahashi T, Asano Y, Amiya E, Hatano M, Tamaki Z, Takata M et al (2014) Clinical correlation of brachial artery flow-mediated dilation in patients with systemic sclerosis. Modern Rheumatol / Jpn Rheumatism Assoc 24(1):106–111
48. Distler O, Distler JH, Scheid A, Acker T, Hirth A, Rethage J et al (2004) Uncontrolled expression of vascular endothelial growth factor and its receptors leads to insufficient skin angiogenesis in patients with systemic sclerosis. Circ Res 95(1):109–116
49. Koch AE, Distler O (2007) Vasculopathy and disordered angiogenesis in selected rheumatic diseases: rheumatoid arthritis and systemic sclerosis. Arthritis Res Ther 9(2):S3
50. Farouk HM, Hamza SH, El Bakry SA, Youssef SS, Aly IM, Moustafa AA et al (2013) Dysregulation of angiogenic homeostasis in systemic sclerosis. Int J Rheum Dis 16(4):448–454
51. Avouac J, Vallucci M, Smith V, Senet P, Ruiz B, Sulli A et al (2013) Correlations between angiogenic factors and capillaroscopic patterns in systemic sclerosis. Arthritis Res Ther 15(2):R55
52. Ferri C, Giuggioli D, Sebastiani M, Colaci M (2007) Treatment of severe scleroderma skin ulcers with recombinant human erythropoietin. Clin Exp Dermatol 32(3):287–290
53. Mulligan-Kehoe MJ, Drinane MC, Mollmark J, Casciola-Rosen L, Hummers LK, Hall A et al (2007) Antiangiogenic plasma activity in patients with systemic sclerosis. Arthritis Rheum 56(10):3448–3458
54. Hebbar M, Peyrat JP, Hornez L, Hatron PY, Hachulla E, Devulder B (2000) Increased concentrations of the circulating angiogenesis inhibitor endostatin in patients with systemic sclerosis. Arthritis Rheum 43(4):889–893
55. Fujimoto M, Hasegawa M, Hamaguchi Y, Komura K, Matsushita T, Yanaba K et al (2006) A clue for telangiectasis in systemic sclerosis: elevated serum soluble endoglin levels in patients with the limited cutaneous form of the disease. Dermatology (Basel, Switzerland) 213(2):88–92
56. Mosca M, Tani C, Vagnani S, Carli L, Bombardieri S (2014) The diagnosis and classification of undifferentiated connective tissue diseases. J Autoimmun 48–49:50–52
57. Voswinkel J, Francois S, Simon JM, Benderitter M, Gorin NC, Mohty M, Fouillard L et al (2013) Use of mesenchymal stem cells (MSC) in chronic inflammatory fistulizing and fibrotic diseases: a comprehensive review. Clin Rev Allergy Immunol 45(2):180–192
58. Moinzadeh P, Nihtyanova SI, Howell K, Ong VH, Denton CP (2012) Impact of hallmark autoantibody reactivity on early diagnosis in scleroderma. Clin Rev Allergy Immunol 43(3):249–255
59. Salazar GA, Assassi S, Wigley F, Hummers L, Varga J, Hinchcliff M et al (2015) Antinuclear antibody-negative systemic sclerosis. Semin Arthritis Rheum 44(6):680–686
60. Bose N, Chiesa-Vottero A, Chatterjee S (2015) Scleroderma renal crisis. Semin Arthritis Rheum 44(6):687–694
61. Maverakis E, Patel F, Kronenberg DG, Chung L, Fiorentino D, Allanore Y et al (2014) International consensus criteria for the diagnosis of Raynaud’s phenomenon. J Autoimmun 48–49:60–65
62. Srivastava N, Hudson M, Tatibouet S, Wang M, Baron M, Fritzler MJ, et al. (2015)Thinking outside the box-The associations with cutaneous involvement and autoantibody status in systemic sclerosis are not always what we expect. Semin Arthritis Rheum
63. Tani C, Carli L, Vagnani S, Talarico R, Baldini C, Mosca M et al (2014) The diagnosis and classification of mixed connective tissue disease. J Autoimmun 48–49:46–49
64. Hudson M, Fritzler MJ (2014) Diagnostic criteria of systemic sclerosis. J Autoimmun 48–49:38–41
65. Mitchell RN (2013) Learning from rejection: what transplantation teaches us about (other) vascular pathologies. J Autoimmun 45:80–89
66. Massie C, Hudson M, Tatibouet S, Steele R, Huynh T, Friztler MJ et al (2014) Absence of an association between anti-Ro antibodies and prolonged QTc interval in systemic sclerosis: a multicenter study of 689 patients. Semin Arthritis Rheum 44(3):338–344
67. Luo Y, Wang Y, Wang Q, Xiao R, Lu Q (2013) Systemic sclerosis: genetics and epigenetics. J Autoimmun 41:161–167
68. Floreani A, Franceschet I, Cazzagon N, Spinazze A, Buja A, Furlan P et al (2015) Extrahepatic autoimmune conditions associated with primary biliary cirrhosis. Clin Rev Allergy Immunol 48(2–3):192–197
69. van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A et al (2013) 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative. Arthritis Rheum 65(11):2737–2747